Literature DB >> 15720991

Recurrent pleomorphic adenoma of the parotid gland.

Peter Zbären1, Isabelle Tschumi, Michel Nuyens, Edouard Stauffer.   

Abstract

BACKGROUND: Surgery of recurrent pleomorphic adenoma presents an increased risk of facial nerve injury and a considerable re-recurrence rate.
METHODS: A series of 33 patients with first recurrence of pleomorphic adenoma of the parotid gland was analyzed. The data were derived from medical records as well as from interviews and clinical examinations of all living patients. Histologic material of the initial and recurrent tumor were reviewed.
RESULTS: Multifocal recurrence and carcinoma in pleomorphic adenoma were observed in 73% and 9% of patients, respectively. The incidence of permanent partial facial nerve injury after surgery was 23% in patients with initial enucleation and 14% in those with initial superficial parotidectomy (including 1 patient with facial nerve resection and 1 patient with a partial facial paresis before recurrence surgery). A subsequent recurrence occurred in 6 patients, all with initial enucleation after a mean time interval of 9 years.
CONCLUSIONS: The preservation of the facial nerve was possible in all but 1 patient treated for the first recurrence with a relatively low rate of permanent partial facial paresis because of the use of the operating microscope and facial nerve monitor. To evaluate the re-recurrence rate, a follow-up of at least 10 years is necessary.

Entities:  

Mesh:

Year:  2005        PMID: 15720991     DOI: 10.1016/j.amjsurg.2004.11.008

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].

Authors:  S F Preuss; O Guntinas-Lichius
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

2.  Warning navigation system using real-time safe region monitoring for otologic surgery.

Authors:  Byunghyun Cho; Masamichi Oka; Nozomu Matsumoto; Riichi Ouchida; Jaesung Hong; Makoto Hashizume
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-11-16       Impact factor: 2.924

3.  Stationary facial nerve paresis after surgery for recurrent parotid pleomorphic adenoma: a follow-up study of 219 cases in Denmark in the period 1985-2012.

Authors:  Anders Nøhr; Simon Andreasen; Marianne Hamilton Therkildsen; Preben Homøe
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-12       Impact factor: 2.503

4.  Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland.

Authors:  G Moonis; P Patel; Y Koshkareva; J Newman; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

5.  Label-free blood serum detection by using surface-enhanced Raman spectroscopy and support vector machine for the preoperative diagnosis of parotid gland tumors.

Authors:  Bing Yan; Bo Li; Zhining Wen; Xianyang Luo; Lili Xue; Longjiang Li
Journal:  BMC Cancer       Date:  2015-10-05       Impact factor: 4.430

6.  Recurrent Pleomorphic Adenoma of the Parotid Gland.

Authors:  Soo Yeon Park; Ki-Taik Han; Min-Cheol Kim; Jin Soo Lim
Journal:  Arch Craniofac Surg       Date:  2016-06-21

7.  Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma.

Authors:  Rosalie A Machado; Sami P Moubayed; Azita Khorsandi; Juan C Hernandez-Prera; Mark L Urken
Journal:  World J Clin Oncol       Date:  2017-02-10

8.  Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature.

Authors:  Luca Oscar Redaelli de Zinis; Michela Piccioni; Antonino Roberto Antonelli; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-25       Impact factor: 2.503

9.  Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.

Authors:  Fernanda Viviane Mariano; Karina Giovanetti; Luis Fernando Vidal Saccomani; André Del Negro; Luiz Paulo Kowalski; Ana Cristina Victorino Krepischi; Albina Altemani
Journal:  Braz J Otorhinolaryngol       Date:  2016-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.